Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modifier genes and heart failure.

P Le Corvoisier1, H Y Park, H A Rockman

  • 1Departments of Medicine Cell Biology and Genetics, Duke University Medical Center, Durham, NC 27710, USA.

Minerva Cardioangiologica
|June 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychiatric disorders in adolescent and young adult cancer survivors in Korea.

ESMO open·2025
Same author

Efficacy and safety of home-based transcranial direct current stimulation as adjunct treatment for cognitive improvement in major depressive disorder: A double-blind, randomized, multi-site clinical trial.

European psychiatry : the journal of the Association of European Psychiatrists·2025
Same author

Immune response to pertussis vaccine in COPD patients.

Scientific reports·2023
Same author

A therapeutic intervention for Alzheimer's disease using ginsenoside Rg3: its role in M2 microglial activation and non-amyloidogenesis.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2021
Same author

Prognostic Utility of Disproportionately Enlarged Subarachnoid Space Hydrocephalus in Idiopathic Normal Pressure Hydrocephalus Treated with Ventriculoperitoneal Shunt Surgery: A Systematic Review and Meta-analysis.

AJNR. American journal of neuroradiology·2021
Same author

Dynamic and subtype-specific interactions between tumour burden and prognosis in breast cancer.

Scientific reports·2020
Same journal

Mechanistic factors of cardiovascular diseases.

Minerva cardioangiologica·2020
Same journal

Robotic-assisted coronary artery bypass grafting: current knowledge and future perspectives.

Minerva cardioangiologica·2020
Same journal

Features of degenerative mitral valve prolapse in the North East of China: repair characteristics, and short-term follow-up results.

Minerva cardioangiologica·2020
Same journal

Myocardial revascularization in chronic coronary syndromes: does viability matter?

Minerva cardioangiologica·2020
Same journal

Extracorporeal membrane oxygenation for COVID-19: effective weapon or futile effort?

Minerva cardioangiologica·2020
Same journal

Heart and endurance sports: excesses are often unhealthy.

Minerva cardioangiologica·2020
See all related articles

Modifier genes significantly impact heart failure outcomes. Combining candidate gene and genome mapping approaches helps identify these genes for better patient risk stratification and therapy response prediction.

Area of Science:

  • Genetics
  • Cardiovascular Diseases
  • Genomic Medicine

Background:

  • Genetic background influences cardiovascular disease variability.
  • Modifier genes affect disease severity and outcome, not its initiation.
  • Identifying modifier genes is crucial for understanding heart failure prognosis.

Purpose of the Study:

  • To identify genes that modify heart failure severity and outcome.
  • To explore the utility of genome mapping in identifying heart failure modifier genes.
  • To integrate candidate gene and genome mapping strategies for comprehensive gene discovery.

Main Methods:

  • Association studies correlating phenotype severity with candidate gene polymorphisms (adrenergic receptors, ACE).
  • Genome mapping in mice to identify Quantitative Trait Loci (QTL) associated with heart failure prognosis.

Related Experiment Videos

  • Experimental induction of heart failure in mice via calsequestrin overexpression.

    • Main Results:

    • Polymorphisms in beta1/beta2 adrenergic receptors and ACE genes correlate with heart failure prognosis.
    • Genome mapping identified two QTL on chromosomes 2 and 3 linked to heart failure prognosis in mice.
    • Successful application of genome mapping for identifying disease modifier genes.

    Conclusions:

    • Both candidate gene and genome mapping strategies are effective for identifying heart failure modifier genes.
    • Identified modifier genes can improve risk assessment and predict therapeutic response in heart failure patients.
    • This integrated approach offers a more rational strategy for personalized cardiovascular medicine.